Developing new economic models to incentivise antibiotic discovery and development activities while safeguarding the efficacy of antibiotics by researching and advocating their appropriate use.
DRIVE-AB Partner Otto Cars is SafeCare Person of the Year
DRIVE-AB partner and ReAct Chairman Prof Otto Cars has been named SafeCare Person of the Year by SafeCare magazine....
DRIVE-AB Holds 2nd Annual General Assembly
DRIVE-AB has held its second annual General Assembly Meeting from 17-18 October in Oslo, Norway. The meeting brought...
DRIVE-AB Partner Presents at World Health Summit Side Event on Innovations in Antimicrobial R&D
On 10 October, 2016, DRIVE-AB Communications co-leader Ursula Theuretzbacher presented at a side...
Special Issue of the WHO Global Action Plan on AMR Newsletter Following UN Meeting
Following the high-level meeting on antimicrobial resistance that was held in New York at...
UN Holds High-Level Meeting on AMR, Leads to Declaration on Drug-Resistant Infections
The United Nations Member States met for the 71st General Assembly in New York this week. A